ALAHIST D- pheniramine maleate, phenylephrine hcl tablet

Alahist D by

Drug Labeling and Warnings

Alahist D by is a Otc medication manufactured, distributed, or labeled by Poly Pharmaceuticals, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Active Ingredient (in each tablet) Purpose

• Pheniramine Maleate 17mg​: Antihistamine
• Phenylephrine HCl 10mg: Nasal Decongestant

USES

Temporarily relieves these symptoms due to the
common cold, hay fever (allergic rhinitis) or other
upper respiratory allergies:

•  runny nose
•  sneezing
•  itching of the nose or throat
•  itchy, watery eyes
•  nasal congestion 
  • reduces swelling of nasal passages

WARNINGS

Do not exceed recommended dosage.

Do not use this product
 if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or
emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use ifyou have

•  a breathing problem such as emphysema or chronic bronchitis
•  glaucoma
•  trouble urinating due to enlargement of the prostate gland
•  heart disease
•  high blood pressure
•  thyroid disease 
• diabetes

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

When using this product

•  excitability may occur, especially in children
•  may cause drowsiness
•  avoid alcoholic drinks
•  alcohol, sedatives, and tranquilizers may increase the drowsiness effect
•  use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if
 nervousness, dizziness, or sleeplessness occur
 symptoms do not improve within 7 days or are accompanied by fever

If pregnant or breast-feeding, ask a health
professional before use.

DIRECTIONS

Directions

• Adults and children 12 years of age and over: 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours
• Children 6 to under 12 years of age Children under 6 consult a doctor:

  1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours

INACTIVE INGREDIENTS

Inactive ingredients
Magnesium Stearate, Microcrystalline Cellulose, Natural Yellow, Sodium Starch Glycolate

QUESTIONS

Questions? Comments?
Call 1-800-882-1041
Manufactured for:
Poly Pharmaceuticals
Huntsville, AL 35763 Rev. 04/17

OTHER INFORMATION

Other information
Store at 15°-30°C (59°-86°F). Supplied in a tight, light-resistant container with a child-resistant cap. Alahist D Tablets are yellow,debossed "A" bisect "D" on one side and plain on the other.

KEEP OUT OF REACH OF CHILDREN

​Keep out of reach of children

​​In case of overdose, get medical help or contact a Poison Control Center right away.

PURPOSE

Antihistamine

Nasal Decongestant

Package Label

INGREDIENTS AND APPEARANCE

ALAHIST D 
pheniramine maleate, phenylephrine hcl tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 50991-776
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PHENIRAMINE MALEATE (UNII: NYW905655B) (PHENIRAMINE - UNII:134FM9ZZ6M)	PHENIRAMINE MALEATE	17.5 mg
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV)	PHENYLEPHRINE HYDROCHLORIDE	10 mg

Inactive Ingredients
Ingredient Name	Strength
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)

Product Characteristics
Color	yellow	Score	2 pieces
Shape	OVAL	Size	11mm
Flavor		Imprint Code	A;D
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 50991-776-01	100 in 1 BOTTLE; Type 0: Not a Combination Product	04/01/2020
2	NDC: 50991-776-02	12 in 1 BLISTER PACK; Type 0: Not a Combination Product	04/01/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part341	04/01/2020

Labeler - Poly Pharmaceuticals, Inc. (198449894)

Establishment
Name	Address	ID/FEI	Business Operations
TG United		172837085	manufacture(50991-776)

Establishment
Name	Address	ID/FEI	Business Operations
Rainbow Gold Products, Inc		800695152	repack(50991-776)